Study guide
7.2 Arterial Stenosis & Occlusion Diagnostic Criteria
CCI Registered Vascular Specialist RVS
Track your progress as you read
Finished sections get a check mark.
1 Introduction & Exam Overview
1.1 About the CCI RVS Exam 1.2 How to Prepare for the RVS Exam
2 Principles of Ultrasound Physics & Transducer Technology
2.1 Ultrasound Waves, Propagation Speed & Attenuation 2.2 Transducer Selection & Beam Formation 2.3 Grayscale Instrumentation & B-Mode Optimization
3 Hemodynamics & Doppler Waveform Analysis
3.1 Hemodynamics & Fluid Energy Principles 3.2 The Doppler Equation & Spectral Optimization 3.3 Spectral Waveform & Color Flow Analysis
4 Extracranial Carotid Duplex Evaluation
4.1 Extracranial Cerebrovascular Anatomy & Protocol 4.2 Differentiating ICA vs ECA & Plaque Characterization 4.3 Carotid Velocity Criteria & Stenosis Staging 4.4 Carotid Endarterectomy and Stent Follow-up
5 Vertebral Artery & Intracranial Cerebrovascular Testing
5.1 Vertebral Artery Duplex & Subclavian Steal 5.2 Transcranial Doppler (TCD & TCDI) Principles & Windows 5.3 Intracranial Hemodynamics & Clinical TCD Applications
6 Lower Extremity Peripheral Arterial Physiologic Testing
6.1 Lower Extremity Arterial Anatomy & Clinical Presentation 6.2 Ankle-Brachial Index (ABI) & Toe-Brachial Index (TBI) 6.3 Segmental Pressure Examination 6.4 Pulse Volume Recording (PVR) & Exercise Testing
7 Lower Extremity Arterial Duplex, Bypass & Stent Surveillance
7.1 Lower Extremity Arterial Duplex Protocol 7.2 Arterial Stenosis & Occlusion Diagnostic Criteria 7.3 Bypass Graft Surveillance Protocols & Criteria 7.4 Stent Surveillance, Pseudoaneurysms & Arterial Emergencies
8 Upper Extremity Arterial Testing & Thoracic Outlet Syndrome
8.1 Upper Extremity Arterial Anatomy & Examination Protocol 8.2 Upper Extremity Occlusive Disease & Vasospastic Disorders 8.3 Thoracic Outlet Syndrome (TOS) Evaluation
9 Lower Extremity Deep & Superficial Venous Duplex Evaluation
9.1 Lower Extremity Venous Anatomy & Hemodynamics 9.2 Venous Duplex Protocol for Deep Vein Thrombosis 9.3 Acute vs Chronic DVT Ultrasound Characteristics 9.4 Special Venous Syndromes & Non-Vascular Findings
10 Chronic Venous Insufficiency, Mapping & Reflux Testing
10.1 Pathophysiology of Venous Reflux & CEAP Classification 10.2 Venous Reflux Examination Protocol & Cutoffs 10.3 Saphenous Vein Mapping Protocol & Criteria 10.4 Endovenous Ablation Surveillance & EHIT Classification
11 Upper Extremity Venous Duplex & Central Vein Evaluation
11.1 Upper Extremity Venous Anatomy & Examination Protocol 11.2 Upper Extremity DVT & Effort Thrombosis 11.3 Central Venous Obstruction & Catheter Surveillance
12 Abdominal Aorta, Aneurysms & EVAR Surveillance
12.1 Abdominal Aorta & Iliac Duplex Protocol 12.2 AAA Screening, Growth Rates & Rupture Risk 12.3 Endovascular Aneurysm Repair (EVAR) Surveillance & Endoleaks
13 Visceral Duplex: Renal, Mesenteric & Hepatoportal Systems
13.1 Renal Artery Duplex: Direct Examination & Velocity Criteria 13.2 Renal Artery Duplex: Indirect Intrarenal Waveform Analysis 13.3 Mesenteric Artery Duplex: Celiac, SMA & IMA 13.4 Hepatoportal Hemodynamics & TIPS Surveillance 13.5 Iliocaval Duplex and Venous Stent Assessment 13.6 Kidney and Liver Transplant Vascular Duplex
14 Hemodialysis Access Planning & Surveillance
14.1 Pre-Operative Vascular Mapping for Dialysis Access 14.2 Duplex Evaluation of AV Fistulas & Grafts 14.3 Dialysis Access Complications & Steal Syndrome
15 Patient Care, Safety, Ergonomics & Quality Standards
15.1 Patient Assessment, Clinical Indications & Physical Exam 15.2 Infection Control, Disinfection & Sterile Technique 15.3 Acoustic Bioeffects, ALARA & Safety 15.4 Sonographer Ergonomics & Laboratory Accreditation 15.5 Emergencies, Pharmacology, Ethics and Preliminary Findings
7.2 Arterial Stenosis & Occlusion Diagnostic Criteria
Key Takeaways Explain This Topic AI
Grade native arterial lesions using validated vessel-specific criteria with anatomy, focal velocities, and distal waveforms.
PSV ratio uses a suitable reference; tandem disease or a poor reference can invalidate a precise-looking result.
Under an explicitly stated 2-to-<4 moderate and ≥4 severe scheme, 280/90 = 3.11 supports 50–74% stenosis.
Optimize low-flow detection and alternative windows before calling occlusion; shadowing alone is not occlusion.
Tardus-parvus supports an upstream hemodynamic problem but does not identify a unique lesion or universal time cutoff.
Last updated: October 2026
Combine anatomy, velocity, and waveform evidence
Native extremity arterial duplex grades disease by integrating visible lumen narrowing, focal velocity acceleration, spectral disturbance, and distal hemodynamics. A laboratory must use written validated criteria for the vessel and examination. A native superficial femoral artery, bypass graft, and stent are not interchangeable settings. Published numeric thresholds vary with the population and reference standard; avoid calling one ratio universally definitive.
The continuity relationship is volume flow = cross-sectional area × mean velocity. A narrowing often accelerates flow locally, but volume flow can also fall as disease becomes severe. Bernoulli's model explains conversion between static pressure and kinetic energy, while real vessels also lose energy through viscosity and disturbance. Therefore velocity does not rise indefinitely as a lumen approaches occlusion.
Obtain a defensible velocity ratio
The PSV ratio compares the peak systolic velocity in a lesion with an appropriate adjacent reference, typically a normal proximal segment: V r = PSV in stenotic jet PSV in suitable proximal reference V_r = \frac{\text{PSV in stenotic jet}}{\text{PSV in suitable proximal reference}} V r = PSV in suitable proximal reference PSV in stenotic jet
Use representative samples with consistent angle correction at or below 60 degrees and parallel to the actual jet. Avoid placing the reference within another stenosis, a major caliber transition, or a highly disturbed segment. A ratio can reduce some systemic effects but cannot cancel every consequence of tandem disease, low cardiac output, arrhythmia, or bad acquisition.
A focal doubling of PSV is commonly used as evidence supporting at least 50% narrowing in some native-vessel schemes. Other validated protocols use different cutoffs. Higher ratios, often around four in common teaching schemes, support more severe narrowing when anatomy and other findings agree. These are interpretive frameworks, not a way to derive an exact percentage from any isolated number.
Explicit example criteria for practice
For the following exercise only, assume the laboratory's validated native femoropopliteal criteria classify ratios 2.0 to less than 4.0 as 50–74% stenosis and ratios at least 4.0 as at least 75% stenosis, provided supporting imaging is concordant. A jet PSV of 280 cm/s and reference PSV of 90 cm/s give 280/90 = 3.11 . Under the stated scheme, that supports 50–74% , not at least 75%. The exact result depends on the stated scheme, so the question must provide it when a boundary matters.
If the reference PSV is depressed by upstream disease, the ratio may overstate the focal lesion. If no suitable normal reference exists, report that limitation. Document the actual velocities and appearance rather than manufacturing a ratio that looks precise but has no defensible denominator.
Recognize the spatial pattern
- Location Findings to assess
- Proximal to a major obstruction Altered resistance, reduced flow, or a high-resistance stump pattern
- At the narrowed segment Visible reduction in lumen and focal acceleration
- Immediately beyond the lesion Flow separation, broadening, and disturbed color/spectral signals
- Farther downstream Dampened amplitude and delayed upstroke when inflow is significantly impaired
A tardus-parvus waveform has a delayed rounded systolic upstroke and reduced amplitude. It supports an upstream hemodynamic problem but is not specific to one lesion or one universal acceleration-time threshold. Compare levels and consider systemic cardiac disease when abnormalities are bilateral. Hyperemia can produce forward diastolic flow without the same delayed upstroke; waveform shape and clinical context matter.
Spectral broadening can be real or artifactual. Reduce excessive gain, narrow an oversized sample gate, check angle, and avoid the wall before attributing window filling to turbulence. A color mosaic can represent aliasing as well as disturbed flow. Raise scale or change acquisition appropriately and sample the region rather than equating every mosaic with severe stenosis.
Occlusion versus undetected slow flow
For suspected occlusion , assess the lumen in several planes and optimize color, power, and spectral Doppler. Lower scale and wall filter appropriately, use gain just below noise, and try an alternative window around calcification. Acute thrombus may be hypoechoic; chronic disease may be more fibrotic or calcified, but grayscale alone cannot assign an exact age.
A high-resistance “thump” proximal to an occlusion and distal collateral reconstitution are supportive. They are not required in every case because branch outflow and collateral pathways change the pattern. No signal behind heavy shadowing is an indeterminate segment until adequate evaluation or additional imaging establishes the anatomy. A PSV ratio is not a meaningful stenosis metric inside a truly occluded lumen.
Trace collateral entry and distal runoff. The deep femoral and genicular pathways may reconstitute an artery beyond a chronic femoropopliteal occlusion. Document lesion length and accessible distal vessels for the interpreting clinician. Endovascular therapy can treat selected occlusions as well as stenoses; occlusion does not automatically require open bypass.
Complete the interpretation
Correlate with ABI/TBI, PVR, symptoms, prior intervention, and the full accessible arterial course. A focal lesion may coexist with inflow and runoff disease. Do not declare the remaining segments normal solely because one local pressure gradient is small or one waveform is preserved. Report lesion location, extent, measurements, collateralization, distal findings, and limitations.
Sudden ischemic symptoms, new neurologic deficit in a limb, or suspected acute graft/native occlusion warrant urgent communication. The examination supplies objective evidence; management depends on the patient's limb viability and clinical assessment, not one threshold detached from the rest of the case.
IAC Vascular Testing criteria and protocol requirements, August 2026 — checked October 18, 2026.